首页> 美国卫生研究院文献>Molecular and Clinical Oncology >Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe
【2h】

Dosimetric comparison between intensity-modulated radiotherapy and RapidArc with single arc and dual arc for malignant glioma involving the parietal lobe

机译:调强放疗与RapidArc单弧和双弧治疗恶性神经胶质瘤累及顶叶的剂量学比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to evaluate the difference in treatment plan quality, monitor units (MUs) per fraction and dosimetric parameters between IMRT (intensity-modulated radiotherapy) and RapidArc with single arc (RA1) and dual arc (RA2) for malignant glioma involving the parietal lobe. Treatment plans for IMRT and RA1 and RA2 were prepared for 10 patients with malignant gliomas involving the parietal lobe. The Wilcoxon matched-pair signed-rank test was used to compare the plan quality, monitor units and dosimetric parameters between IMRT and RA1 and RA2 through dose-volume histograms. Dnear-max (D2%) to the left lens, right lens and left optical nerve in RA1 were less compared with those in IMRT; D2% to the right lens and right optic nerve in RA2 were less compared with those in IMRT. D2% to the optic chiasma in RA2 was small compared with that in RA1. The median dose (D50%) to the right lens and right optic nerve in RA1 and RA2 was less compared with the identical parameters in IMRT, and D50% to the brain stem in RA2 was less compared with that in RA1. The volume receiving at least 45 Gy (V45) or V50 in normal brain tissue (whole brain minus the planning target volume 2; B-P) in RA1 was less compared with that in IMRT. V30, V35, V40, V45, or V50 in B-P in RA2 was less compared with that in IMRT. The MUs per fraction in RA1 and RA2 were significantly less compared with those in IMRT. All differences with a P-value<0.05 were considered to be significantly different. In conclusion, RA1 and RA2 markedly reduced the MUs per fraction, and spared partial organs at risk and B-P compared with IMRT.
机译:本研究的目的是评估IMRT(强度调制放疗)与RapidArc联合使用单弧(RA1)和双弧(RA2)的恶性肿瘤的治疗计划质量,每部分监测单位(MUs)和剂量参数的差异胶质瘤累及顶叶。已为10例涉及顶叶的恶性神经胶质瘤患者制定了IMRT和RA1和RA2的治疗计划。使用Wilcoxon配对配对带符号秩检验通过剂量-体积直方图比较IMRT与RA1和RA2之间的计划质量,监测单位和剂量参数。与IMRT相比,RA1中左晶状体,右晶状体和左视神经的Dnear-max(D2%)要少。与IMRT相比,RA2中右晶状体和右视神经的D2%较少。与RA1相比,RA2中视神经chi裂的D2%很小。与IMRT中相同的参数相比,RA1和RA2中右晶状体和右视神经的中位剂量(D50%)少,与RA1中相比,RA2中对脑干的D50%较少。与IMRT相比,RA1中正常脑组织(全脑减去计划目标体积2; B-P)中接受至少45 Gy(V45)或V50的体积较小。 RA2中B-P中的V30,V35,V40,V45或V50低于IMRT。与IMRT相比,RA1和RA2中每部分的MU明显更少。 P值<0.05的所有差异均被认为具有显着差异。总之,与IMRT相比,RA1和RA2显着降低了每个部位的MU,并避免了处于风险中的部分器官和B-P。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号